Last $15.49 USD
Change Today -0.22 / -1.40%
Volume 1.9M
ARWR On Other Exchanges
As of 2:09 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

arrowhead research corp (ARWR) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/6/14 - $27.63
52 Week Low
09/23/13 - $4.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

arrowhead research corp (ARWR) Related Businessweek News

No Related Businessweek News Found

arrowhead research corp (ARWR) Details

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and Adipotide, which is in Phase I clinical trial for the treatment for obesity and related metabolic disorders. Its platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown, and induces endosomal escape; and Homing Peptides platform, a library of short peptides. The company also develops DPC-enabled RNAi therapeutic, a pre-clinical stage product to treat an undisclosed orphan liver disease. It also has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.

54 Employees
Last Reported Date: 12/18/13
Founded in 2003

arrowhead research corp (ARWR) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $579.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $305.1K
Chief Operating Officer and Head of R&D
Total Annual Compensation: $417.5K
Compensation as of Fiscal Year 2013.

arrowhead research corp (ARWR) Key Developments

Arrowhead Research Corporation Announces Earnings Results for the Third Quarter and Cash Flow Results for the Nine Months Ended June 30, 2014

Arrowhead Research Corporation announced earnings results for the third quarter and cash flow results for the nine months ended June 30, 2014. For the quarter, the company announced net loss attributable to Arrowhead for the quarter was $11.6 million, or $0.22 per share based on 51.9 million weighted average shares outstanding. This compares with a net loss attributable to Arrowhead of $6.1 million, or $0.23 per share based on 26.1 million weighted average shares outstanding, for the quarter ended June 30, 2013. For the nine months, the company announced net cash used in operating activities for the first nine months of fiscal 2014 was $24.5 million, compared with $13.6 million in the prior year period. The increase in cash used in operating activities is consistent with the change in operating expenses.

Arrowhead Research Corp. to Report Q3, 2014 Results on Aug 12, 2014

Arrowhead Research Corp. announced that they will report Q3, 2014 results at 5:00 PM, US Eastern Standard Time on Aug 12, 2014

Arrowhead Research Corp., Q3 2014 Earnings Call, Aug 12, 2014

Arrowhead Research Corp., Q3 2014 Earnings Call, Aug 12, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARWR:US $15.48 USD -0.2284

ARWR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ARWR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ARWR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4,768.8x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3,928.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARROWHEAD RESEARCH CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at